Panelists discuss how BTK inhibitors represent a promising new oral therapy class that could address both inflammatory and ...

Researches at the University of Cincinnati's Gardner Neuroscience Institute could have discovered a new oral treatment that ...

NEW YORK, July 21, 2025) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully hum ...

YORK dad Sid Gornall, whose son was diagnosed with mitochondrial disease has welcomed news of a medical breakthrough.

In an unexpected discovery, the analysis revealed an increase in phagocytosis markers in classical monocytes, suggesting that nasal foralumab may enhance their ability to clear amyloid plaques. This ...

A large, prospective study implicates high levels of interleukin 6 with severity of diabetic retinopathy and shows it may be ...

Synendos Therapeutics appoints Dr. George Garibaldi as CMO to enhance phase 2 clinical development of its lead drug asset SYT-510: Basel, Switzerland Saturday, July 19, 2025, 15:3 ...

UniSA scientists may have transformed how symptoms of Parkinson’s disease are managed with a breakthrough that allows treatment to be managed weekly for the disease that affects more than 100,000 ...

Swiss clinical-stage CNS disease specialist Synendos Therapeutics has named Dr George Garibaldi as its chief medical officer ...

Well-known Ballina local Craig Nolte died from lyssavirus following a bat bite last year, despite receiving treatment.